SMMT - Summit Therapeutics Inc
IEX Last Trade
13
0.140 1.077%
Share volume: 2,106,166
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.86
0.14
1.09%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-11 | 2022-08-11 | 2022-11-09 | 2023-03-09 | 2023-05-11 | 2023-08-09 | |
| Cash flow financing | 25.187 M | 0.000 | 74.997 M | 520.060 M | 80.112 M | -80.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -19.001 M | -19.217 M | -8.555 M | 5.191 M | -13.131 M | -29.273 M | |
| Net income | -21.397 M | -16.771 M | -21.385 M | -19.229 M | -542.376 M | -14.717 M | |
| Depreciation | 615.000 K | 591.000 K | 712.000 K | 596.000 K | 375.000 K | 471.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 870.000 K | 238.000 K | 140.000 K | 349.000 K | 0.000 | 0.000 | |
| Investing Cashflow | -361.000 K | -293.000 K | 20.000 K | 10.000 K | -645.063 M | 207.000 K | |
| Net Borrowings | -71.068 M | -51.842 M | -132.614 M | 162.400 M | -143.843 M | -120.242 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -361.000 K | -293.000 K | 20.000 K | 10.000 K | -53.000 K | -20.000 K | |
| Cash Change | 77.450 M | 57.335 M | 121.971 M | 348.607 M | 241.932 M | 215.014 M |